Belvedere Trading LLC Adverum Biotechnologies, Inc. Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.54 - $10.3 $5,130 - $97,850
9,500 New
9,500 $5,000
Q1 2022

Apr 20, 2022
SELL
$1.23 - $1.95 $104,304 - $165,360
-84,800 Closed
0 $0
Q4 2021

Jan 25, 2022
SELL
$1.74 - $2.4 $188,268 - $259,680
-108,200 Reduced 56.06%
84,800 $131,000
Q3 2021

Oct 19, 2021
BUY
$2.08 - $3.6 $295,360 - $511,200
142,000 Added 278.43%
193,000 $390,000
Q2 2021

Jul 23, 2021
BUY
$3.36 - $10.56 $171,360 - $538,560
51,000 New
51,000 $159,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email